Clinical Trials Logo

Filter by:
NCT ID: NCT03408873 Completed - Bipolar Disorder Clinical Trials

CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

This is a prospective study using customized adherence enhancement (CAE) and long-acting injectable (LAI) antipsychotic in 30 individuals with bipolar disorder (BD) at risk for treatment non-adherence. The CAE approach is expected to improve treatment adherence, as well as improve BD symptoms, functioning and treatment attitudes among subjects with bipolar disorder.

NCT ID: NCT03415230 Completed - Anxiety Clinical Trials

Effect of Therapeutic Massage on Sleep Quality and Stress Levels in Women With Breast Cancer

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

This is a randomized control trial to test the effectiveness of therapeutic massage on the sleep quality and the stress levels in women that have completed their treatment for breast cancer.

NCT ID: NCT03417141 Completed - Lichen Planopilaris Clinical Trials

Valchlor in the Treatment of Lichen Planopilaris

Start date: April 1, 2018
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to assess the potential effectiveness of once daily application of Valchlor in decreasing disease activity in patients with Lichen Planopilaris. The primary measurement of efficacy will be with the Lichen Planopilaris Activity Index (LPPAI) before and after 6 months of treatment. Secondary measures of efficacy will be the mean follicular density, Physician Global assessment (PGA) score, and the Dermatology Quality of Life Index (DQLI) score before and after six months of therapy.

NCT ID: NCT03418428 Completed - Gastric Cancer Clinical Trials

Intestinal Microbiome After Gastrectomy

DiGMA
Start date: April 1, 2018
Phase:
Study type: Observational

The gastric barrier plays a major role in the maintanance of the distal intestinal microbiome composition. It has been shown before that the use of gastric acid suppression medication, such as proton pump inhibitors, are associated with distinctive alterations of the intestinal microbiome. Foremost, the invasion of predominantly oral bacteria, like Veillonella and Streptococcus species, were a resurring finding in previous reports. Gastric cancer treatment includes the total or subtotal resection of the stomach which can influence the gastric acid production. However, the influence by alterations in gastric milieu after this treatment on the composition of the intestinal microbiome is not well studied. Therefore, the intestinal microbiome of patients after total or subtotal gastrectomy and its influence on intestinal inflammation and gut permeability will be studied.

NCT ID: NCT03418701 Completed - Obesity Clinical Trials

Health-Smart for Weight Loss at UF Jax Clinics

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The study will test the effectiveness of a culturally sensitive, evidence-based, multi-component, behavioral program for treating obesity called Health-Smart. This program is being implemented by Community Health Workers at the primary care centers and followed by either of two physician-implemented behavioral counseling programs to prevent weight gain--programs that are implemented quarterly over 12 months.

NCT ID: NCT03437980 Completed - Patient Compliance Clinical Trials

Propofol Spinal Procedural Sedation for Cesarean Section

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Patient's safety and satisfaction are major concerns of anesthesiologists and obstetricians. According to evidence, guidelines and quality markers, regional anesthesia is preferred over general anesthesia in obstetric surgery. A high level of anxiety is present in obstetric patients preoperatively. Patients with high anxiety tend to prefer general anesthesia for cesarean section. The anxiety can be reduced variably by non-pharmacologic and pharmacologic methods. The evidence supports the benefits of procedural sedation for distressed, anxious pregnant women.

NCT ID: NCT03438162 Completed - Clinical trials for Diabetes Mellitus, Type 2

Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Type 2 diabetes mellitus (T2DM) is a chronic progressive disease that affects more than 400 million people worldwide. There are a few studies evaluating ADRs in diabetics. Many patients experience ADRs soon after hospital discharge which can be attributed to the changes in the pharmacotherapy during hospitalization. Education and counseling of diabetic patients has been shown to improve medication adherence and clinical outcomes. Studies that included medical patients revealed that education can significantly reduce risk of ADRs after hospital discharge. Pharmacotherapeutic education is a part of comprehensive education of diabetics that is focused on a proper use of medications, prevention and early detection of ADRs.

NCT ID: NCT03441126 Completed - Sepsis Clinical Trials

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

Bright STAR
Start date: April 1, 2018
Phase:
Study type: Observational

This study will test the hypothesis that reliable implementation of an evidence-based clinical practice guideline for evaluation of patients with signs and symptoms of sepsis will decrease antibiotic use in pediatric intensive care units (PICUs).

NCT ID: NCT03442712 Completed - Obesity Clinical Trials

Auricular Acupressure Integrated With Mobile Device for Weight Reduction

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Obesity is a common global health problem. A three-arm randomised waitlist-controlled feasibility trial is proposed. A total of 59 subjects (19-21 subjects per arm) will be recruited. The three groups are AA plus smartphone application (experimental group); AA only (comparison group); and Waitlist control group. In the experimental group, seeds will be applied on six specific ear acupoints of the subjects by the researcher. Subjects will be requested to apply pressure on the acupoints thrice per day. They will install a smartphone App which will send out regular reminders for pressing, allow the subjects to input the number of bowel open, compliance rate, and difficulties entered during the process for timely advice. The total treatment period will be 8 weeks. Outcome measures will be conducted at baseline and postintervention at 8 weeks, including obesity and anthropometric index, leptin concentration and adiponectin level. Patient satisfaction towards the therapy, the use of the smartphone application and the implementation of the treatment protocol will be determined.

NCT ID: NCT03443440 Completed - Clinical trials for Postoperative Cognitive Dysfunction

Prognostic Factors Associated With Postoperative Cognitive Dysfunction After Surgery

POCDCOG
Start date: April 1, 2018
Phase:
Study type: Observational

A longitudinal observational study examining preoperative, intraoperative and postoperative factors associated with Postoperative Cognitive Dysfunction in patients older than the age of 50.